BioSpace News Archive

FDA

Integer Receives FDA Approval for Thin Wall Radial Introducer Kit, RadialSeal™Engineered for optimal device compatibility and ease of insertion

Integer Holdings Corporation announced that it has received FDA and CE Mark approval for their new radial access introducer, RadialSeal™.

August 3, 2018
·
2 min read
Business

Vital Therapies Announces Upcoming 2018 Second Quarter Financial Results Conference Call With Webcast

Vital Therapies, Inc. will release its second quarter 2018 financial results after the market closes on Tuesday, August 7, 2018 followed by a conference call at 4:30 p.m. ET, which will be open to the public via telephone and webcast.

August 3, 2018
·
1 min read
Business

NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash GuidanceManagement to Host Conference Call Today at 4:30 p.m. ET

NewLink Genetics Corporation announced its clinical plan and strategy, reported consolidated financial results for the second quarter of 2018, and revised its cash guidance.

August 3, 2018
·
13 min read
Drug Development

OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial

OmniSeq, Inc.® announced it is participating as a CLIA-certified/accredited laboratory for the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial

August 3, 2018
·
4 min read
Drug Development

Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic

ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration

August 3, 2018
·
4 min read
Business

Apellis Pharmaceuticals Reports Second Quarter 2018 Business Update and Financial Results

Commenced Phase 3 Trial of APL-2 in Paroxysmal Nocturnal Hemoglobinuria (PNH); APL-2 in Geographic Atrophy (GA) Remains On Track to Advance into Phase 3 in 2H18

August 3, 2018
·
9 min read
Business

Axsome Therapeutics to Report Second Quarter 2018 Financial Results on August 8, 2018

Axsome to host conference call and webcast on Wednesday, August 8, 2018 at 8:00 AM Eastern Time

August 3, 2018
·
3 min read
Business

Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018

Myriad Genetics, Inc. announced that it will hold its fiscal fourth-quarter 2018 sales and earnings conference call with investors and analysts at 4:30 p.m. EDT on Tuesday, August 14, 2018.

August 3, 2018
·
2 min read
Business

Velano Vascular Adds Healthcare Veterans David R. Strand and Dr. Gary Kurtzman to Board of Directors

Vascular access technology innovator Velano Vascular today welcomed Safeguard Scientifics Healthcare Managing Director, Gary Kurtzman, MD and seasoned Chief Executive Officer and former hospital system Chief Operating Officer David R. Strand to its Board of Directors.

August 3, 2018
·
3 min read
Business

PharmaVOICE Magazine Announces the 2018 PharmaVOICE 100 and Red Jacket Award Honorees

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformative individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue.

August 3, 2018
·
3 min read